Gaurav, Kamil and Andrew return to discuss the latest news on the European economy. Kamil unpacks the latest trade and industrial production data and what they reveal about the impact of higher U.S. tariffs. Is the weakness just a reversal of earlier frontloading in pharmaceuticals, or are tariffs starting to bite? Meanwhile, Andrew discusses the key takeaways from the text of the EU-U.S. trade agreement and what it suggests about the likely path of tariff rates. The damage from tariffs is set to grow and uncertainty remains high, but the team share a sense that the risks of recession in Europe have receded and even manage to agree on the odds.

Questions or Comments, please email us at helpeconomy@moodys.com. We would love to hear from you. 

To stay informed and follow the insights of Moody's Analytics economists, visit Economic View.